The use of the Actiwatch-Neurologica system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington's disease.
Huntington's disease (HD) is a neurodegenerative disorder characterised by cognitive, psychiatric and motor abnormalities including a range of involuntary movements. Currently, assessment of these movements involves the use of subjective rating scales such as the Unified Huntington's Disease Rating Scales (UHDRS) for bradykinesia and maximal dystonia and chorea, without any objective measures. As new therapies emerge, it is critical that an objective means of evaluating these abnormal movements is developed and we have investigated the use of a wrist-worn activity monitor, the Actiwatch-Neurologica, to determine whether these movements can be measured. In addition, this activity monitor and subjective reports were used to objectively measure the degree of sleep disruption in these same HD patients. Eight patients with mild-moderate HD and 8 age- and sex-matched control subjects wore the monitor for a period of 48 hours and recorded in a diary whether they were asleep or awake for each hour over the 2-day period. Assessment of various movement parameters revealed that HD patients exhibited significantly greater total and maximum activity levels and spent longer performing high acceleration movements while they were awake compared with controls. During sleep, patients not only showed significantly more activity and spent more time making high acceleration movements, but they also made significantly more movements than control subjects. These results demonstrate that the Actiwatch-Neurologica activity monitor can be used to objectively assess movements in HD patients during periods of high activity as well as during sleep.
Hurelbrink
Carrie B
CB
Centre for Brain Repair, Forvie Site, Robinson Way, Cambridge CB2 2PY, UK. cbh20@cam.ac.uk
Lewis
Simon J G
SJ
Barker
Roger A
RA
D000203:Activities of Daily Living; D000328:Adult; D016022:Case-Control Studies; D002940:Circadian Rhythm / Q000502:physiology; D020820:Dyskinesias / Q000503:physiopathology*; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D018670:Monitoring, Ambulatory / Q000379:methods*; D012890:Sleep / Q000502:physiology*; D011795:Surveys and Questionnaires; D014851:Wakefulness / Q000502:physiology*
Arch Neurol. 1991 Feb;48(2):210-4
1825167
Acta Neurol Scand. 1993 Mar;87(3):171-7
8475685
Sleep. 1991 Dec;14(6):540-5
1798888
Clin Neuropharmacol. 1993 Feb;16(1):36-45
8422656
Clin Neuropharmacol. 2001 Sep-Oct;24(5):280-3
11586112
J Neurosci Methods. 1997 Jun 6;74(1):107-12
9210580
J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):629-35
12438461
Eur Neurol. 2001;46 Suppl 1:11-7
11741098
Mov Disord. 2001 May;16(3):481-8
11391742
J Am Geriatr Soc. 1993 Aug;41(8):837-41
8340562
Neurophysiol Clin. 1995;25(2):66-77
7603414
J Neurol. 1991 Jul;238(4):203-8
1832711
J Neurol Neurosurg Psychiatry. 1991 Nov;54(11):976-9
1800670
Neurology. 1985 Nov;35(11):1672-4
2932657
J Neural Transm Park Dis Dement Sect. 1994;8(1-2):117-21
7893373
Mov Disord. 2001 Jan;16(1):58-61
11215593
Electroencephalogr Clin Neurophysiol. 1993 Oct;89(5):359-62
7691576
Mov Disord. 1996 Mar;11(2):136-42
8684382